Patent Ductus Arteriosus After Premature Birth
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Patent Ductus Arteriosus After Premature Birth trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Patent Ductus Arteriosus After Premature Birth trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Patent ductus arteriosus (PDA), the most common cardiovascular complication of prematurity, is associated with higher mortality and morbidities in extremely low…
Background: Among preterm infants, those born at a gestational age less than 26 weeks are considered the most vulnerable with a high risk of short- and long-ter…
Estimate the risks and benefits of active treatment versus expectant management of a symptomatic patent ductus arteriosus (sPDA) in premature infants.
Purpose of the research Everyone is born with an opening between the chambers of the heart, called a ductus arteriosus. In most people, it closes on its own, bu…